Additionally, TGFβ-dominant cancers such as CESC, GBM, HNSC, and STAD may use CD59 as an immune escape mechanism by blocking MAC formation and increasing the population of Treg, MDSC, and TAM. Here, CD59 is linked to glioblastoma.